Informace o projektu
Next Generation Sequencing Platform for Targeted Personalized Therapy of Leukemia
(NGS-PTL)
- Kód projektu
- 7E13008
- Období řešení
- 9/2013 - 10/2015
- Investor / Programový rámec / typ projektu
-
Ministerstvo školství, mládeže a tělovýchovy ČR
- Podpora projektů sedmého rámcového programu Evropského společenství pro výzkum, technologický rozvoj a demonstrace (2007 až 2013)
- Fakulta / Pracoviště MU
- Středoevropský technologický institut
This project aims at developing a European Hematological/HTS platform of scientists for improving outcomes for therapeutic interventions on acute and chronic leukemias and at develop strategies to personalize treatments and tailor therapies to different stratified groups of leukemia patients, with the goal of optimizing their efficacy and safety through a deeper and deeper understanding of the influence of genetic/genomic alterations on leukemias pathogenesis and treatment response (i.e. “personalized therapy”). Moreover, the final aim will be the identification of novel prognostic biomarkers for acute and chronic leukemias, as well as of molecular biomarkers and/or genomic profiles for the assessment of minimal residual disease. The originality of this project is to perform systematic deep genomic/transcriptomic studies on well-clinically-characterized leukemia patients, by exploiting HTS technologies able to quickly produce data with a good cost-effectiveness and an unprecedented resolution.
Publikace
Počet publikací: 23
2014
-
Detecting minimal residual disease in patients with chronic lymphocytic leukemia using 8-color flow cytometry protocol in routine hematological practice.
International Journal of Laboratory Hematology, rok: 2014, ročník: 36, vydání: 2, DOI
-
Identification of novel sequence variations in microRNAs in chronic lymphocytic leukemia
Carcinogenesis, rok: 2014, ročník: 35, vydání: 5, DOI
-
TP53 Mutation Analysis in Clinical Practice: Lessons From Chronic Lymphocytic Leukemia
Human Mutation, rok: 2014, ročník: 35, vydání: 6, DOI